Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35618786)
Watch
English
Cell-cycle targeted therapies
scientific article published on January 2004
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
14700606
retrieved
9 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Cell-cycle targeted therapies
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
14700606
retrieved
9 August 2017
author
Charles Swanton
object named as
Charles Swanton
series ordinal
1
0 references
publication date
1 January 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
14700606
retrieved
9 August 2017
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed ID
14700606
retrieved
9 August 2017
volume
5
1 reference
stated in
Europe PubMed Central
PubMed ID
14700606
retrieved
9 August 2017
page(s)
27-36
1 reference
stated in
Europe PubMed Central
PubMed ID
14700606
retrieved
9 August 2017
issue
1
1 reference
stated in
Europe PubMed Central
PubMed ID
14700606
retrieved
9 August 2017
cites work
Cell cycle control and cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Restriction Point for Control of Normal Animal Cell Proliferation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest points
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New functional activities for the p21 family of CDK inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Crystal structure of a gamma-herpesvirus cyclin-cdk complex
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclin E-CDK2 is a regulator of p27Kip1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Are p27 and p21 cytoplasmic oncoproteins?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
To cycle or not to cycle: a critical decision in cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chromosome 11q13 markers and D-type cyclins in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclin E and survival in patients with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A gene-expression signature as a predictor of survival in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structural basis for Chk1 inhibition by UCN-01
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activation of the cell death program by inhibition of proteasome function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
FR901228 causes mitotic arrest but does not alter microtubule polymerization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901321-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(03)01321-4
1 reference
stated in
Europe PubMed Central
PubMed ID
14700606
retrieved
9 August 2017
PubMed ID
14700606
1 reference
stated in
Europe PubMed Central
PubMed ID
14700606
retrieved
9 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit